Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
1,259 news
and
4,837 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
Blogs
Recent blog posts on this topic.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad)...
Theravance ($THRX) plans to break apart into two publicly traded companies. The South San Francisco-based biotech...
Bristol-Myers Squibb ($BMY) just gained an inside regulatory track in the frantic race to get new interferon-free...
Radius Health joined the lineup of biotechs announcing big new venture rounds today. The Cambridge, MA-based developer,...
Now that the successful biopharma team of Roger Newton and Tim Mayleben has reunited to run an upstart--Esperion--with...
Driven to test another amyloid-beta mechanism in Alzheimer's, Acumen Pharmaceuticals has wrapped up the first closing...
Copyright © thinkBiotech As I continue to investigate global biotechnology for Scientific American and international...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Some top life sciences investors have backed France-based vaccine developer Genticel in an €18.2 million round of...
Copyright © thinkBiotech This live infographic dynamically shows the number of pending patent expirations by year for...
OPKO Health ($OPK) announced today that it is poised to acquire Israel-based Prolor Biotech in an all-stock transaction...
AstraZeneca's partnership spree of the last two months has gone Down Under. As the company shrinks its internal...
Copyright © thinkBiotech I continue to measure global biotechnology innovation in the fifth edition of Scientific...
Panel from left to right: Jose-Carlos Gutiérrez-Ramos, Pfizer; Briggs Morrison, AstraZeneca; John Carroll,...
The city of Chicago is hoping to take advantage of the spotlight of the annual BIO convention to build up its biotech...
Copyright © thinkBiotech This infographic from DrugPatentWatch shows that Sanofi Aventis...
Here's a multibillion-dollar question: With their improved cash positions, will pharma companies increase spending this...
After delivering data from multiple rounds of trials on all-oral combos against hepatitis C, pharma runners appear to...
Copyright © thinkBiotech Join Michael Salgaller and I as we will be signing our books at the BIO bookstore on Tuesday...
Top Sources: Business of Biotechnology
- Biotech Blog
- News
- Health Beat
- frontendofinnovation.blogspot.com
- Nature Biotechnology
- The Biotech Weblog
- policyinnovations.org
- Science Progress
- LinkedIn Answers: Technology
- World Pharma News / Published News
account